Engineered cellular immunotherapies in cancer and beyond.
Engineered cellular immunotherapies in cancer and beyond.
复制标题
DOI:
10.1038/s41591-022-01765-8
复制
发表时间:
2022-04
期刊:
影响因子:
82.9
通讯作者:
June, Carl H.
中科院分区:
文献类型:
--
作者:
Finck, Amanda V.;Blanchard, Tatiana;Roselle, Christopher P.;Golinelli, Giulia;June, Carl H.
This year marks the tenth anniversary of cell therapy with chimeric antigen receptor (CAR)-modified T cells for refractory leukemia. The widespread commercial approval of genetically engineered T cells for a variety of blood cancers offers hope for patients with other types of cancer, and the convergence of human genome engineering and cell therapy technology holds great potential for generation of a new class of cellular therapeutics. In this Review, we discuss the goals of cellular immunotherapy in cancer, key challenges facing the field and exciting strategies that are emerging to overcome these obstacles. Finally, we outline how developments in the cancer field are paving the way for cellular immunotherapeutics in other diseases.
登录
查看更多内容
DOI:
10.1016/j.bbmt.2015.05.001
发表时间:
2015-08
期刊:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
影响因子:
--
作者:
Ciurea SO;Thall PF;Milton DR;Barnes TH;Kongtim P;Carmazzi Y;López AA;Yap DY;Popat U;Rondon G;Lichtiger B;Aung F;Afshar-Kharghan V;Ma Q;Fernández-Viña M;Champlin RE;Cao K
通讯作者:
Cao K
影响因子:
46.9
作者:
Choi, Bryan D.;Yu, Xiaoling;Maus, Marcela V.
通讯作者:
Maus, Marcela V.
DOI:
10.1038/nri3212
发表时间:
2012-05-11
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
12.4
作者:
Agarwal, Shiwani;Hanauer, Julia D. S.;Buchholz, Christian J.
通讯作者:
Buchholz, Christian J.
影响因子:
28.2
作者:
Adusumilli PS;Zauderer MG;Rivière I;Solomon SB;Rusch VW;O'Cearbhaill RE;Zhu A;Cheema W;Chintala NK;Halton E;Pineda J;Perez-Johnston R;Tan KS;Daly B;Araujo Filho JA;Ngai D;McGee E;Vincent A;Diamonte C;Sauter JL;Modi S;Sikder D;Senechal B;Wang X;Travis WD;Gönen M;Rudin CM;Brentjens RJ;Jones DR;Sadelain M
通讯作者:
Sadelain M